Paglalarawan

Combination products include therapeutic or diagnostic products that combine a drug or biologic with a drug delivery device. According to a report by StrategyHelix, the global combination products market is set to increase by US$ 45.60 billion during 2022-2028, growing at a CAGR of 6.8% sa panahon ng pagtataya.

Ang ulat ay nagbibigay ng napapanahong data ng laki ng merkado para sa panahon 2018-2021 at forecast na 2028 covering key market aspects like sales value for combination products. The global combination products market is segmented on the basis of product, application, and region. On the basis of product, the global combination products market has been segmented into drug/biologic-device combination products, drug-biologic combination products, and drug-device-biologic combination products. By application, the global combination products market has been segmented into cardiovascular, diabetes, cancer treatment, respiratory diseases, at iba pa. Geographically, the global combination products market is segmented into North America, Asya Pasipiko, Europa, Middle East and Africa, and Latin America.

The global combination products market is highly competitive. The report also includes the profiles of leading companies such as Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cipla Limited, CosMED Pharmaceutical Co. Ltd., Enable Injections Inc., Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Sanofi S.A., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, The 3M Company, Ypsomed AG.

Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the combination products market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

Saklaw ng Ulat

Produkto: drug/biologic-device combination products, drug-biologic combination products, and drug-device-biologic combination products
Paglalapat: cardiovascular, diabetes, cancer treatment, respiratory diseases, at iba pa
Rehiyon: Hilagang Amerika, Asya Pasipiko, Europa, Middle East and Africa, and Latin America
Taon na itinuturing: Ang ulat na ito ay sumasaklaw sa panahon 2018 sa 2028

Mga Pangunahing Benepisyo para sa mga Stakeholder

– Get a comprehensive picture of the global combination products market
– Pinpoint ang mga sektor ng paglago at mga trend para sa pamumuhunan

Talaan ng mga Nilalaman

1. Kahulugan ng merkado
2. Paraan ng pananaliksik
3. Data ng merkado at pananaw
3.1 Mga pagtatantya sa laki ng merkado
3.2 Pagtataya ng Pagtataya
4. Combination products market by product
4.1 Drug/biologic-device combination products
4.2 Drug-biologic combination products
4.3 Drug-device-biologic combination products
5. Combination products market by application
5.1 Cardiovascular
5.2 Diabetes
5.3 Cancer treatment
5.4 Respiratory diseases
5.5 Ang iba naman
6. Combination products market by region
6.1 Hilagang Amerika
6.2 Asya Pasipiko
6.3 Europa
6.4 Middle East and Africa
6.5 Latin America
7. Mga profile ng kumpanya
7.1 Abbott Laboratories
7.2 B. Braun Melsungen AG
7.3 Becton, Dickinson and Company
7.4 Boston Scientific Corporation
7.5 Cipla Limited
7.6 CosMED Pharmaceutical Co., Ltd.
7.7 Enable Injections, Inc.
7.8 Johnson & Johnson
7.9 Medtronic plc
7.10 Novo Nordisk A/S
7.11 Sanofi S.A.
7.12 Smith & Nephew plc
7.13 Stryker Corporation
7.14 Terumo Corporation
7.15 The 3M Company
7.16 Ypsomed AG
8. Apendiks
8.1 Tungkol sa StrategyHelix
8.2 Pagtanggi